HHS Importation Task Force Moves Into Writing Phase; Still Seeking Input From Health Canada
This article was originally published in The Pink Sheet Daily
The task force is required to conclude its written report by the fall; however, HHS Secretary Thompson has asked the task force to share its findings as soon as possible. Canadian international pharmacy representative argues that Canadian law allows pharmacies to broker three-way international transactions to sell pharmaceuticals to U.S. customers.
You may also be interested in...
The findings of the HHS importation task force and the new Medicare drug benefit will lead to lower prices for consumers, CMS Administrator McClellan tells NACDS. Fairer international pricing, including reduced prices of generics in other countries, is also a way forward, he adds.
“We are prepared to enter discussions toward a decree at FDA’s earliest convenience,” Able says in letter to FDA. Company is pursuing consent decree instead of responding to FDA Form 483 report citing manufacturing deficiencies. The letter follows CEO Maury’s resignation the previous day.